跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 981 条关于
“Cu-PrIm”
全部
981
临床试验
563
药物
210
机构
19
资讯
189
3个月前
Engineered Nanozymes Reprogram the Colorectal Cancer Microenvironment to Overcome Chemoresistance and Immune Exclusion
去年
Cutia Therapeutics' CU-40102 Demonstrates Efficacy in Phase III Trial for Androgenetic Alopecia
去年
PRIM-ER Trial Finds Palliative Care Training in Emergency Departments Does Not Reduce Hospital Admissions
去年
CU Cancer Center's Innovative Approaches Lead to Higher Survival Rates
去年
CU Anschutz Launches Novel Immunotherapy Trial for Autoimmune Encephalitis
上个月
CU Anschutz Clinical Research Recruitment Program Doubles Study Inquiries Through Website Redesign
3年前
Microbiome Modulation with SIM01 Shows Promise for Long COVID Treatment in Randomized Trial
去年
Clarity Pharmaceuticals and SpectronRx Partner for Phase III Trial Manufacturing of Cu-64 SAR-bisPSMA
去年
Golfers Against Cancer Funds CU Cancer Center Research on Pediatric CAR T-cell Therapy
去年
CU Medicine Introduces Asia's First Histotripsy 2.0 System for Liver Tumour Treatment
第 1 页,共 19 页
上一页
下一页